Infecting just one tumor with a virus could boost the systemic effectiveness of cancer immunotherapy
A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic ...
Mar 5, 2014